. Author manuscript; available in PMC: 2026 Mar 31.

Published in final edited form as: Cell Oncol (Dordr). 2022 Jan 7;45(1):19–40. doi: 10.1007/s13402-021-00640-x

Table 2.

Cell type assignments summary

Cell Type	Total %	% Control	% D1	%D2
Brain (Neuron, CNS, Cerebral Cortex	11.97	4.5	3.2	4.23
Epithelial	0.3	0	0.14	0.14
Embryonic Stem Cell (ESC)	72	24.4	21.78	26.16
Hematopoietic Stem Cells
^a(T1-LT) ZYGOT	0.43 0.73	0.43 0.14	0.14 0.14	0 0.43
Spleen and Lymph Nodes	4.67	1.60	1.46	1.60
Endothelial	0.3	0	0.14	0.14
Thymus	0.58	0.14	0	0.43
^bHSPC	1.6	0.29	0.58	0.73
Progenitor	4	1.16	0.43	2.48
Cancer Lymphocytic	1.30	0.4	0.14	0.73

^aT1-HSC CD31⁺VE-cadherin⁺CD45⁻CD41^lowc-Kit⁺ in E11 aorta–gonad–mesonephros Hematopoietic Stem Cells, LT-HSCs Lin^–, c-Kit^+, Sca1^+, CD34^–, Flk2⁻ Hematopoietic Stem Cells, T1-HSC CD31⁺VE-cadherin⁺CD45⁻CD41^lowc-Kit⁺ in E11 aorta–gonad–mesonephros Hematopoietic Stem Cells

^bHSPC Hematopoietic Stem Cells and Progenitor Cells